AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glafis M 2mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Ersa Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glafis M 2mg/500mg Tablet PR

Diabetam M, a 2mg/500mg tablet, combats type 2 diabetes in adults. This dual-action medication, categorized as an anti-diabetic agent, effectively manages blood glucose levels. Consume Diabetam M with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Diabetam M is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks, juice) to counter this. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. Diabetam M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended by your healthcare provider.

Uses of Glafis M 2mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glafis M 2mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Glafis M 2mg/500mg Tablet PR should be ingested with a meal.

Common Side effects of Glafis M 2mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glafis M 2mg/500mg Tablet PR:

Follow your physician's instructions or refer to the product label for proper administration. Glafis M 2mg/500mg Tablet PR should be ingested with a meal.

How Glafis M 2mg/500mg Tablet PR works:

Glafis M 2mg/500mg tablets are a dual-action antidiabetic formulation containing glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glafis M 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glafis M 2mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glafis M 2mg/500mg tablets. Evidence indicates potential infant harm due to the medication's toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glafis M 2mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glafis M 2mg/500mg Tablet PR. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Exercise caution when administering Glafis M 2mg/500mg Tablet PR to individuals with hepatic impairment. Dosage modification of Glafis M 2mg/500mg Tablet PR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Glafis M 2mg/500mg Tablet PR should typically commence at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Glafis M 2mg/500mg Tablet PR :

Should you forget a dose of Glafis M 2mg/500mg PR Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glafis M 2mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glafis M 2mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glafis M 2mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glafis M 2mg/500mg Tablet PR and seek immediate medical attention.
Glafis M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glafis M 2mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glafis M 2mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glafis M 2mg/500mg Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Glafis M 2mg/500mg Tablet PR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glafis M 2mg/500mg Tablet...
73
MRP 85
14% off